Evidence map›Paper›PMID 41335328›Full record

ReviewAdvances in therapy2026

Optimizing the Use of Inhaled Corticosteroid/Long-Acting β

Gabriel Garcia, Kittipong Maneechotesuwan, Prabhuram Krishnan, Manish Verma, Nicolas Roche

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabriel GarciaRespiratory Research Center, La Plata, Argentina.
Kittipong ManeechotesuwanDivision of Respiratory Disease and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Prabhuram KrishnanGSK, Asia House, 23 Rochester Park, Singapore, Singapore.
Manish VermaGSK, Mumbai, India. manish.8.verma@gsk.com.
Nicolas RocheAP-HP Centre, Institut Cochin (INSERM, UMR 1016), Pneumologie, Hôpital Cochin, Université de Paris Cité, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current clinical recommendations for asthma management are based on a symptom-driven, stepwise approach; however, the effects of patient characteristics and patient preference should be considered as they can influence adherence and, in turn, treatment effectiveness. In this Practical Approach article, an international group of asthma specialists reviews the current evidence to be considered when prescribing (as initial or secondary therapy) conventional maintenance inhaled corticosteroid (ICS)/long-acting β

Indexed as

Adrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsAsthmaAdministration, InhalationDrug CombinationsDrug Therapy, CombinationFormoterol FumarateHumansSeverity of Illness IndexAdrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsDrug CombinationsFormoterol FumarateAsthmaInhaled corticosteroidsInhaled therapyLong-acting β2-agonistsMaintenance and reliever therapyMART

Identifiers

PMID41335328
PMCPMC12909425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.